| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $11.91B | -2.5% |
| R&D Expense | $229.0M | +48.7% |
| SG&A Expense | $276.0M | +6.6% |
| Pre-tax Income | -$51.0M | -104.6% |
| Income Tax | $455.0M | -58.6% |
| Net Income | -$429.0M | -136.8% |
| EPS (Basic) | -$0.54 | -137.0% |
| EPS (Diluted) | -$0.54 | -137.0% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $2.88B | -42.4% |
| Accounts Receivable | $366.0M | +8.6% |
| Current Assets | $6.51B | -15.3% |
| Total Assets | $38.48B | -5.1% |
| Current Liabilities | $2.93B | +10.2% |
| Long-term Debt | $5.57B | -2.5% |
| Total Liabilities | $18.95B | +1.3% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $3.22B | -24.7% |
| Investing Cash Flow | -$2.98B | -59.7% |
| Financing Cash Flow | -$2.36B | +20.4% |
| Stockholders' Equity |
| $19.35B |
| -12.1% |